(Q53862563)

21 May 2018

title

High-dose hepatitis B vaccine in patients waiting for lung transplantation. (English)

1 reference

21 May 2018

1 reference

1 reference

Mary S Hayney

1

1 reference

21 May 2018

Deborah L Welter

2

1 reference

21 May 2018

Ann Marie Reynolds

3

1 reference

21 May 2018

Mary Francois

4

1 reference

21 May 2018

Robert B Love

5

1 reference

21 May 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

21 May 2018

published in

Pharmacotherapy

1 reference

21 May 2018

volume

23

1 reference

21 May 2018

issue

5

1 reference

21 May 2018

page(s)

555-560

1 reference

21 May 2018

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Hepatitis B vaccine responsiveness in Connecticut public safety personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

The humoral immune response to influenza vaccination in lung transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Hepatitis B vaccines in patients with chronic renal failure before dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Influenza vaccination in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Annual influenza vaccination: immune response in patients over 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Production of interferon-gamma and interleukin-10 after inactivated hepatitis A immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Response to hepatitis B vaccine: multiple HLA genes are involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Relationship of HLA-DQAI alleles and humoral antibody following measles vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.555.32194

10.1592/PHCO.23.5.555.32194

21 January 2018

Identifiers

DOI

1 reference

21 May 2018

1 reference

21 May 2018